close

Fundraisings and IPOs

1 2 3 76
Number of results: 1516
Date Company Amount Funding type Investors Therapeutic area Type of Information
2019-02-14 Passage Bio (USA - PA) $115.5 million series A financing round OrbiMed Advisors (USA - NY) Frazier Healthcare Partners (USA - WA) Versant Ventures (USA - CA) New Leaf Venture Partners (USA - NY - CA) Vivo Capital (USA - CA) Lilly Asia Ventures (China) Rare diseases - Genetic diseases - CNS diseases Series A financing round
2019-01-25 Nordic Nanovector (Norway) NOK 222 million ($ 26 million) private placement Cancer - Oncology Private placement
2019-01-25 Corbus Pharmaceuticals (USA - MA) private placement Inflammatory diseases Private placement
2019-01-24 Wave Life Sciences (USA - MA) $150 million private placement Rare diseases - Genetic diseases Private placement
2019-01-24 Wave Life Sciences (USA - MA) $150 million private placement Rare diseases - Genetic diseases Private placement
2019-01-23 Orion (Finland) € 100 million loan European Investment Bank (EIB) Cancer - Oncology - Neurological diseases - Respiratory diseases Loan
2019-01-23 PTC Therapeutics (USA - NJ) private placement Rare diseases - Genetic diseases Private placement
2019-01-23 Selecta Biosciences (USA - MA) $30 million private placement Private placement
2019-01-22 Alvotech (Iceland) $300 million private placement Autoimmune diseases - Inflammatory diseases - Cancer - Oncology Private placement
2019-01-04 Aimmune Therapeutics (USA - CA) $ 170 million loan KKR (USA - NY) Allergic diseases Loan
2019-01-03 Cabaletta Bio (USA - PA) $50 million series B financing round Adage Capital (USA - MA) 5AM Ventures (USA - MA) Deerfield Management Company (USA - NY) Boxer Capital of Tavistock Group  (Bahamas) Redmile Group (USA - CA) Cormorant Capital (USA - IL) Autoimmune diseases Series B financing round
2018-12-21 Nabriva Therapeutics (Ireland) $75 million loan Hercules Capital (USA - CA) Infectious diseases Loan
2018-12-20 Geneuro (Switzerland) €7.5 million credit line GNEH (France) Neurodegenerative diseases Loan
2018-12-14 Axovant Sciences (Bermuda - USA - NY) $ 30 million private placement Rare diseases - Genetic diseases Private placement
2018-11-26 Adrenomed (Germany) € 24 million series D financing round HBM Healthcare Investments (Switzerland) Wellington Partners (Germany - UK) Inflammatory diseases Series D financing round
2018-11-02 Omeicos Therapeutics (Germany) € 17 million series C financing round Forbion Capital Partners (The Netherlands) Vesalius Biocapital (Luxembourg) SICAR (Luxembourg) VC Fonds Technologie Berlin (Germany) Hightech Gruenderfonds II GmbH & Co. KG (HTGF) (Germany) KfW Group (Germany) The Falck Revocable Trust, members of the management Cardiovascular diseases - Ophtalmological diseases Series C financing round
2018-10-30 Orchard Therapeutics (UK) IPO Rare diseases - Genetic diseases IPO
2018-10-30 Newron Pharmaceuticals (Italy) € 40 million loan European Investment Bank (EIB) CNS diseases - Neurological diseases Loan
2018-10-25 89Bio (USA - CA) $60 million series A financing round OrbiMed (USA - NY) Longitude Capital (USA - CA) RA Capital Management (USA - MA) Pontifax (Israel) Hepatic diseases - Liver diseases Series A financing round
2018-10-23 Cerevel Therapeutics (USA - MA) $350 million financing round Pfizer (USA - NY) Bain Capital (USA - MA) CNS diseases Financing round